Bioxytran, Inc. (OTCMKTS:BIXT) Sees Significant Increase in Short Interest

Bioxytran, Inc. (OTCMKTS:BIXT) saw a significant growth in short interest in December. As of December 15th, there was short interest totalling 77,600 shares, a growth of 254.3% from the November 30th total of 21,900 shares. Based on an average trading volume of 83,100 shares, the short-interest ratio is presently 0.9 days.

Bioxytran Price Performance

OTCMKTS BIXT remained flat at $0.09 during trading hours on Thursday. The company had a trading volume of 166 shares, compared to its average volume of 82,897. The business’s fifty day moving average is $0.09 and its 200 day moving average is $0.10. The stock has a market cap of $7.64 million, a P/E ratio of -8.80 and a beta of -0.80. Bioxytran has a 52-week low of $0.08 and a 52-week high of $0.17.

Bioxytran Company Profile

Bioxytran, Inc, a clinical stage pharmaceutical company, focuses on the development, manufacture, and commercialization of therapeutic drugs to address hypoxia in humans. The company’s lead drug candidate is BXT-25, an oxygen-carrying small molecule consisting of bovine hemoglobin stabilized with a co-polymer for use in the treatment of hypoxic conditions in the brain resulting from stroke, and hypoxic conditions in wounds to prevent necrosis and to promote healing.